Table 2.
Topical medication of patients.
| Patient | Topical medication (within 1 month) |
|---|---|
| G1 | Sodium hyaluronate, Diquafosol tetrasodium |
| G2 | Cyclosporine, Diquafosol tetrasodium, Vitamin A |
| G3 | Sodium hyaluronate, Artificial tear, Cyclosporine, Diquafosol tetrasodium |
| G4 | Rebamipide |
| G5 | Sodium hyaluronate, Diquafosol tetrasodium, Rebamipide |
| G6 | Sodium hyaluronate, Artificial tear, Rebamipide, Methylpredonisolon |
| G7 | Sodium hyaluronate, Artificial tear, Rebamipide, Diquafosol tetrasodium |
| G8 | Sodium hyaluronate, Epinastine, Rebamipide, Levofloxacin |
| G9 | Sodium hyaluronate, Rebamipide, Artificial tear, Ofloxacin |
| G10 | Sodium hyaluronate, FK-506, Ofloxacin |
| G11 | Diquafosol tetrasodium |
| G12 | Sodium hyaluronate, brinzolamide ophthalmic suspension |
| C1 | Sodium hyaluronate |
| C2 | none |
| C3 | none |
| C4 | none |
| C5 | none |
| C6 | Sodium hyaluronate |
| C7 | Epinastine, Methylpredonisolon |
| C8 | none |
| C9 | Sodium hyaluronate; Epinastine |
| C10 | Sodium hyaluronate |
G: GVHD, C: non-GVHD.